Cited by 3,162Cancer Genomics and DiagnosticsCancer Cells and MetastasisEvolution and Genetic Dynamics

The DOI matches its Crossref record; 104 of the 107 references it cites were found in a registry or an index, and 3 are not checked yet.

Clonal evolution in cancer

Open access

Greaves, Mel, Maley, Carlo C.·2012·Nature

DOI 10.1038/nature10762PMC PMC3367003

Open this paper in CoChat — free account

Abstract

Cancers evolve by a reiterative process of clonal expansion, genetic diversification and clonal selection within the adaptive landscapes of tissue ecosystems. The dynamics are complex, with highly variable patterns of genetic diversity and resulting clonal architecture. Therapeutic intervention may destroy cancer clones and erode their habitats, but it can also inadvertently provide a potent selective pressure for the expansion of resistant variants. The inherently Darwinian character of cancer is the primary reason for this therapeutic failure, but it may also hold the key to more effective control.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature10762

Cites

104 of 107 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Cancer Statistics, 2008
Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
Tumour evolution inferred by single-cell sequencing
Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Önder, T. T., Jiang, G., Tao, K. X., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,429
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C. R., Poppleton, H., Koçak, M., Hogg, T. L., Fuller, C. E., Hamner, J. B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,253

Flagged first, then by citations

Show all 104 references

Sorted by citations

Items 801–900 of 1,004

Representing genetic variation with synthetic DNA standards
Deveson, I. W., Chen, W. Y., Wong, T., Hardwick, S. A., Andersen, S. B., Nielsen, L. K., Mattick, J. S., & Mercer, T. R. (2016) · Nature Methods · doi:10.1038/nmeth.3957 · Cited by 47
Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome
Criado, I., Rodríguez‐Caballero, A., Gutiérrez, M. L., Pedreira, C. E., Alcoceba, M., Nieto, W. G., Teodósio, C., Bárcena, P., Romero, A. E., Fernández-Navarro, P., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.183954 · Cited by 47
Microenvironmental niche divergence shapes BRCA1-dysregulated ovarian cancer morphological plasticity
Heindl, A., Khan, A. M., Rodrigues, D. N., Eason, K., Sadanandam, A., Orbegoso, C., Punta, M., Sottoriva, A., Lise, S., Banerjee, S. N., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06130-3 · Cited by 51
Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test
González‐Billalabeitia, E., Conteduca, V., Wetterskog, D., Jayaram, A., & Attard, G. (2018) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-018-0098-x · Cited by 49
Cartilage Oligomeric Matrix Protein initiates cancer stem cells through activation of Jagged1-Notch3 signaling
Παπαδάκος, Κ. Σ., Bartoschek, M., Rodriguez, C., Gialeli, C., Jin, S.-B., Lendahl, U., Pietras, K., & Blom, A. M. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.11.007 · Cited by 47
Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications
Rossari, F., Zucchinetti, C., Buda, G., & Orciuolo, E. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00467-7 · Cited by 46
An emerging role for cellular crosstalk in the cancer stem cell niche
Oshimori, N., Guo, Y., & Taniguchi, S. (2021) · The Journal of Pathology · doi:10.1002/path.5655 · Cited by 50
A Systems Approach to Brain Tumor Treatment
Park, J. H., de Lomana, A. L. G., Marzese, D. M., Juarez, T., Feroze, A. H., Hothi, P., Cobbs, C., Patel, A. P., Kesari, S., Huang, S., et al. (2021) · Cancers · doi:10.3390/cancers13133152 · Cited by 50
Reconstructing the tumor architecture into organoids
Luo, Z., Zhou, X., Mandal, K., He, N., Wennerberg, W., Qu, M., Jiang, X., Sun, W., & Khademhosseini, A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113839 · Cited by 49
Induction of Wnt-Inducible Signaling Protein-1 Correlates with Invasive Breast Cancer Oncogenesis and Reduced Type 1 Cell-Mediated Cytotoxic Immunity: A Retrospective Study
Klinke, D. J. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003409 · Cited by 47
Cancer genome and tumor microenvironment: Reciprocal crosstalk shapes lung cancer plasticity
Mansouri, S., Heylmann, D., Stiewe, T., Kracht, M., & Savai, R. (2022) · eLife · doi:10.7554/elife.79895 · Cited by 45
Alternative Treatments For Melanoma: Targeting BCL-2 Family Members to De-Bulk and Kill Cancer Stem Cells
Mukherjee, N., Schwan, J. V., Fujita, M., Norris, D. A., & Shellman, Y. G. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.145 · Cited by 46
Combination of Ponatinib with Hedgehog Antagonist Vismodegib for Therapy-Resistant BCR-ABL1–Positive Leukemia
Katagiri, S., Tauchi, T., Okabe, S., Minami, Y., Kimura, S. H., Maekawa, T., Naoe, T., & Ohyashiki, K. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1777 · Cited by 46
Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemia
Bhola, P. D., Mar, B. G., Lindsley, R. C., Ryan, J. A., Hogdal, L. J., Vo, T. T., DeAngelo, D. J., Galinsky, I. A., Ebert, B. L., & Letai, A. G. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82908 · Cited by 46
The possible role of burden of therapy on the risk of myeloma extramedullary spread
Mangiacavalli, S., Pompa, A., Ferretti, V. V., Klersy, C., Cocito, F., Varettoni, M., Cartia, C. S., Cazzola, M., & Corso, A. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2847-z · Cited by 48
Cell-cell fusion as a mechanism of DNA exchange in cancer
Searles, S. C., Santosa, E. K., & Bui, J. D. (2017) · Oncotarget · doi:10.18632/oncotarget.23715 · Cited by 46
Evolution of cancer cell populations under cytotoxic therapy and treatment optimisation: insight from a phenotype-structured model
de Almeida, L. N., Bagnerini, P., Fabrini, G., Hughes, B. D., & Lorenzi, T. (2019) · ESAIM Mathematical Modelling and Numerical Analysis · doi:10.1051/m2an/2019010 · Cited by 44
Passenger mutations can accelerate tumour suppressor gene inactivation in cancer evolution
Wodarz, D., Newell, A. C., & Komarova, N. L. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0967 · Cited by 46
Immune contexture analysis in immuno‐oncology: applications and challenges of multiplex fluorescent immunohistochemistry
Shakya, R., Nguyen, T. H., Waterhouse, N. J., & Khanna, R. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1183 · Cited by 46
Luminal epithelial cells within the mammary gland can produce basal cells upon oncogenic stress
Hein, S., Haricharan, S., Johnston, A. N., Toneff, M. J., Reddy, J. P., Dong, J., Bu, W., & Li, Y. (2015) · Oncogene · doi:10.1038/onc.2015.206 · Cited by 49
Single-cell copy number calling and event history reconstructionPreprint
Kuipers, J., Tuncel, M. A., Ferreira, P., Jahn, K., & Beerenwinkel, N. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.28.065755 · Cited by 46
Clonally heritable gene expression imparts a layer of diversity within cell types
Mold, J. E., Weissman, M. H., Ratz, M., Hagemann-Jensen, M., Hård, J., Eriksson, C., Toosi, H., Berghenstråhle, J., Ziegenhain, C., von Berlin, L., et al. (2024) · Cell Systems · doi:10.1016/j.cels.2024.01.004 · Cited by 47
Evolutionary fingerprints of epithelial-to-mesenchymal transition
Perelli, L., Zhang, L., Mangiameli, S. M., Giannese, F., Mahadevan, K. K., Peng, F., Citron, F., Khan, H., Le, C. N., Gurreri, E., et al. (2025) · Nature · doi:10.1038/s41586-025-08671-2 · Cited by 50
Ecological paradigms to understand the dynamics of metastasis
Amend, S. R., Roy, S. G., Brown, J. S., & Pienta, K. J. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.005 · Cited by 45
Tumour heterogeneity and immune-modulation
Jamal‐Hanjani, M., Thanopoulou, E., Peggs, K. S., Quezada, S. A., & Swanton, C. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.04.006 · Cited by 45
The Future of Combining Carbon-Ion Radiotherapy with Immunotherapy: Evidence and Progress in Mouse Models
Shimokawa, T., Ma, L., Ando, K., Sato, K., & Imai, T. (2016) · International Journal of Particle Therapy · doi:10.14338/ijpt-15-00023.1 · Cited by 46
A microscopic landscape of the invasive breast cancer genome
Ping, Z., Xia, Y., Shen, T., Parekh, V., Siegal, G. P., Eltoum, I.-E. A., He, J., Chen, D., Deng, M., Xi, R., et al. (2016) · Scientific Reports · doi:10.1038/srep27545 · Cited by 45
Tumor Heterogeneity in Lymphomas: A Different Breed
Schürch, C. M., Federmann, B., Quintanilla‐Martínez, L., & Fend, F. (2017) · Pathobiology · doi:10.1159/000475530 · Cited by 45
Prominent features of the amino acid mutation landscape in cancer
Szpiech, Z. A., Strauli, N. B., White, K. A., Ruiz, D. G., Jacobson, M. P., Barber, D. L., & Hernandez, R. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183273 · Cited by 45
Implication for Cancer Stem Cells in Solid Cancer Chemo-Resistance: Promising Therapeutic Strategies Based on the Use of HDAC Inhibitors
Roca, M. S., Gennaro, E. D., & Budillon, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070912 · Cited by 45
Current and Future Horizons of Patient-Derived Xenograft Models in Colorectal Cancer Translational Research
Inoue, A., Deem, A. K., Kopetz, S., Heffernan, T. P., Draetta, G. F., & Carugo, A. (2019) · Cancers · doi:10.3390/cancers11091321 · Cited by 46
TERT promoter mutated circulating tumor DNA as a biomarker for prognosis in hepatocellular carcinoma
Oversoe, S. K., Clement, M. S., Pedersen, M. H., Weber, B., Aagaard, N. K., Villadsen, G. E., Grønbæk, H., Hamilton-Dutoit, S. J., Sørensen, B. S., & Kelsen, J. (2020) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2020.1837928 · Cited by 45
Glioblastoma multiforme: a multi-omics analysis of driver genes and tumour heterogeneity
Herrera-Oropeza, G. E., Angulo‐Rojo, C., Gástelum-López, S. A., Varela‐Echavarría, A., Hernández-Rosales, M., & Aviña‐Padilla, K. (2021) · Interface Focus · doi:10.1098/rsfs.2020.0072 · Cited by 45
A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome
Schell, M. J., Yang, M., Missiaglia, E., Delorenzi, M., Soneson, C., Yue, B., Nebozhyn, M. V., Loboda, A., Bloom, G., & Yeatman, T. J. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0143 · Cited by 42
Molecular Evolution of Metaplasia to Adenocarcinoma in the Esophagus
Grady, W. M., & Yu, M. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5090-8 · Cited by 45
Resisting Resistance
Božić, I., & Nowak, M. A. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-042716-094839 · Cited by 42
The tumor ecosystem in head and neck squamous cell carcinoma and advances in ecotherapy
Gong, Y., Bao, L., Xu, T., Yi, X., Chen, J., Wang, S., Pan, Z., Huang, P. C., & Ge, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01769-z · Cited by 47
Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment
Peroni, E., Randi, M. L., Rosato, A., & Cagnin, S. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02841-8 · Cited by 51
Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis
Ballabio, E., & Milne, T. A. (2012) · Cancers · doi:10.3390/cancers4030904 · Cited by 46
Adapting Clinical Paradigms to the Challenges of Cancer Clonal Evolution
Murugaesu, N., Chew, S. K., & Swanton, C. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.02.026 · Cited by 42
Co-Evolution of Somatic Variation in Primary and Metastatic Colorectal Cancer May Expand Biopsy Indications in the Molecular Era
Kim, R. D., Schell, M. J., Teer, J. K., Greenawalt, D. M., Yang, M., & Yeatman, T. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126670 · Cited by 44
Veterinary oncology: Biology, big data and precision medicine
Pang, L. Y., & Argyle, D. J. (2016) · The Veterinary Journal · doi:10.1016/j.tvjl.2016.03.009 · Cited by 44
Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells
Wu, J., Lü, M., Li, Y., Shang, Y.-K., Wang, S.-J., Meng, Y., Wang, Z., Zs, L., Chen, H., Chen, Z.-N., et al. (2016) · Oncogene · doi:10.1038/onc.2016.89 · Cited by 44
Emerging targets for glioblastoma stem cell therapy
Ahmad, R., Mohammad, R., Aaron, A., Karen, E., & Bijangi‐Vishehsaraei, K. (2016) · Journal of Biomedical Research · doi:10.7555/jbr.30.20150100 · Cited by 44
Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines
Salawu, A., Fernando, M. S., Hughes, D. J., Reed, M., Woll, P. J., Greaves, C. L., Day, C., Alhajimohammed, M., & Sisley, K. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.259 · Cited by 44
Natural and chemotherapy-induced clonal evolution of tumors
Ibragimova, M. K., Tsyganov, M. M., & Литвяков, Н. В. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917040022 · Cited by 44
Beyond molecular tumor heterogeneity: protein synthesis takes control
y Cajal, S. R., Castellví, J., Hümmer, S., Peg, V., Pelletier, J., & Sonenberg, N. (2018) · Oncogene · doi:10.1038/s41388-018-0152-0 · Cited by 44
The Spatiotemporal Evolution of Lymph Node Spread in Early Breast Cancer
Barry, P. A., Vatsiou, A. I., Spiteri, I., Nichol, D., Cresswell, G. D., Acar, A., Trahearn, N., Hrebien, S., García-Murillas, I., Chkhaidze, K., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3374 · Cited by 43
Self-citation
Eco‐oncology: Applying ecological principles to understand and manage cancer
Reynolds, B. A., Oli, M. W., & Oli, M. K. (2020) · Ecology and Evolution · doi:10.1002/ece3.6590 · Cited by 42
Progression signature underlies clonal evolution and dissemination of multiple myeloma
Shen, Y. J., Mishima, Y., Shi, J., Sklavenitis‐Pistofidis, R., Redd, R. A., Moschetta, M., Manier, S., Roccaro, A. M., Sacco, A., Tai, Y., et al. (2020) · Blood · doi:10.1182/blood.2020005885 · Cited by 44
Challenges with biomarkers in cancer drug discovery and development
Dumbrava, E. I., Meric‐Bernstam, F., & Yap, T. A. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1479740 · Cited by 45
Cancer Risk in Barrett’s Esophagus: A Clinical Review
Beydoun, A. S., Stabenau, K. A., Altman, K. W., & Johnston, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076018 · Cited by 44
HPV oncogenes expressed from only one of multiple integrated HPV DNA copies drive clonal cell expansion in cervical cancer
Yu, L., Majerčiak, V., Lobanov, A. V., Mirza, S., Band, V., Liu, H., Cam, M., Hughes, S. H., Lowy, D. R., & Zheng, Z. (2024) · mBio · doi:10.1128/mbio.00729-24 · Cited by 42
Cell competition: Winning out by losing notch
Alcolea, M. P., & Jones, P. H. (2014) · Cell Cycle · doi:10.4161/15384101.2014.988027 · Cited by 42
Biopsy for liver cancer: How to balance research needs with evidence‐based clinical practice
Sherman, M., & Bruix, J. (2014) · Hepatology · doi:10.1002/hep.27563 · Cited by 43
Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling
Alberghina, L., Gaglio, D., Gelfi, C., Moresco, R. M., Mauri, G., Bertolazzi, P., Messa, C., Gilardi, M. C., Chiaradonna, F., & Vanoni, M. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00362 · Cited by 45
Tumorsphere assay provides more accurate prediction of in vivo responses to chemotherapeutics
Kim, S., & Alexander, C. M. (2013) · Biotechnology Letters · doi:10.1007/s10529-013-1393-1 · Cited by 43
An Evolutionary Model of Tumor Cell Kinetics and the Emergence of Molecular Heterogeneity Driving Gompertzian Growth
West, J., Hasnain, Z., Macklin, P., & Newton, P. K. (2016) · SIAM Review · doi:10.1137/15m1044825 · Cited by 45
Modeling Tumor Clonal Evolution for Drug Combinations Design
Zhao, B., Hemann, M. T., & Lauffenburger, D. A. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.02.001 · Cited by 42
Translational models of tumor angiogenesis: A nexus of in silico and in vitro models
Soleimani, S., Shamsi, M., Ghazani, M. A., Modarres, H. P., Valente, K. P., Saghafian, M., Ashani, M. M., Akbari, M., & Sanati‐Nezhad, A. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.01.013 · Cited by 43
The intranuclear PEX domain of MMP involves proliferation, migration, and metastasis of aggressive adenocarcinoma cells
Okusha, Y., Eguchi, T., Sogawa, C. A., Okui, T., Nakano, K., Okamoto, K., & Kozaki, K. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27040 · Cited by 44
Hypermutable DNA chronicles the evolution of human colon cancer
Naxerova, K., Brachtel, E. F., Salk, J. J., Seese, A. M., Power, K. A., Abbasi, B., Snuderl, M., Chiang, S., Kasif, S., & Jain, R. K. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400179111 · Cited by 40
Probabilistic Dimensionality Reduction via Structure Learning
Wang, L., & Mao, Q. (2017) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2017.2785402 · Cited by 42
Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble?
Moutinho-Ribeiro, P., Macedo, G., & Melo, S. A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00779 · Cited by 43
The evolution of multicellularity and cancer: views and paradigms
Nedelcu, A. M. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190992 · Cited by 46
In-vitro tumor microenvironment models containing physical and biological barriers for modelling multidrug resistance mechanisms and multidrug delivery strategies
Rahmanian, M., Seyfoori, A., Ghasemi, M., Shamsi, M., Kolahchi, A. R., Modarres, H. P., Sanati‐Nezhad, A., & Majidzadeh‐A, K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.04.024 · Cited by 42
Breast Cancer Heterogeneity in Primary and Metastatic Disease
Kalinowski, L., Saunus, J. M., Reed, A. E. M., & Lakhani, S. R. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-20301-6_6 · Cited by 47
Evolution of intratumoral phenotypic heterogeneity: the role of trait inheritance
Gallaher, J. A., & Anderson, A. R. A. (2013) · Interface Focus · doi:10.1098/rsfs.2013.0016 · Cited by 42
Molecular imaging of breast cancer: present and future directions
Alcántara, D., Leal, M. P., GarcÃa-Bocanegra, I., & García‐Martín, M. L. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00112 · Cited by 43
HIT’nDRIVE: Multi-driver Gene Prioritization Based on Hitting Time
Shrestha, R., Hodzic, E., Yeung, J., Wang, K., Sauerwald, T., Dao, P., Anderson, S. A., Beltran, H., Rubin, M. A., Collins, C. C., et al. (2014) · Lecture notes in computer science · doi:10.1007/978-3-319-05269-4_23 · Cited by 41
Evolutionary perspective of cancer: myth, metaphors, and reality
Arnal, A., Újvári, B., Crespi, B. J., Gatenby, R. A., Tissot, T., Vittecoq, M., Ewald, P. W., Casali, A., Ducasse, H., Jacqueline, C. M., et al. (2015) · Evolutionary Applications · doi:10.1111/eva.12265 · Cited by 41
Effect of homotypic and heterotypic interaction in 3D on the E-selectin mediated adhesive properties of breast cancer cell lines
Chandrasekaran, S., Geng, Y., DeLouise, L. A., & King, M. R. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.08.052 · Cited by 41
Hyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumors
Donovan, P., Cato, K., Legaie, R., Jayalath, R., Olsson, G., Hall, B. I., Olson, S., Boros, S., Reynolds, B. A., & Harding, A. S. (2014) · Molecular BioSystems · doi:10.1039/c3mb70484j · Cited by 40
NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?
Friberg, S. G., & Nyström, A. M. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0172-2 · Cited by 43
A Nanoprinted Model of Interstitial Cancer Migration Reveals a Link between Cell Deformability and Proliferation
Panagiotakopoulou, M., Bergert, M., Taubenberger, A. V., Guck, J. R., Dimos Poulikakos, A., & Ferrari, A. (2016) · ACS Nano · doi:10.1021/acsnano.5b07406 · Cited by 41
Pan‐cancer RNA‐seq data stratifies tumours by some hallmarks of cancer
Frost, F. G., Cherukuri, P. F., Milanovich, S. J., & Boerkoel, C. F. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14746 · Cited by 42
Towards multi-omics characterization of tumor heterogeneity: a comprehensive review of statistical and machine learning approaches
Lee, D., Park, Y., & Kim, S. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa188 · Cited by 41
Clonal Architecture of EGFR Mutation Predicts the Efficacy of EGFR-Tyrosine Kinase Inhibitors in Advanced NSCLC: A Prospective Multicenter Study (NCT03059641)
Ai, X., Cui, J., Zhang, J., Chen, R., Lin, W. H., Xie, C., Liu, A., Zhang, J., Yang, W., Hu, X., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3063 · Cited by 41
MPL resolves genetic linkage in fitness inference from complex evolutionary histories
Sohail, M. S., Louie, R. H. Y., McKay, M. R., & Barton, J. P. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0737-3 · Cited by 38
Tolerant/Persister Cancer Cells and the Path to Resistance to Targeted Therapy
Swayden, M., Chhouri, H., Anouar, Y., & Grumolato, L. (2020) · Cells · doi:10.3390/cells9122601 · Cited by 47
Extrachromosomal DNA (ecDNA) in cancer pathogenesis
Wu, S., Bafna, V., & Mischel, P. S. (2021) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2021.01.001 · Cited by 41
Predicting Colorectal Cancer Occurrence in IBD
Yalchin, M., Baker, A., Graham, T. A., & Hart, A. L. (2021) · Cancers · doi:10.3390/cancers13122908 · Cited by 42
Emerging role for leucine-rich repeat-containing G-protein-coupled receptors LGR5 and LGR4 in cancer stem cells
Goidts, V., Nakata, S., & Phillips, E. (2014) · Cancer Management and Research · doi:10.2147/cmar.s57846 · Cited by 41
Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise
Abd, G. M., Laird, M. C., Ku, J. C., & Li, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1227884 · Cited by 41
Automated histological classification for digital pathology images of colonoscopy specimen via deep learning
Byeon, S., Park, J., Cho, Y. A., & Cho, B. (2022) · Scientific Reports · doi:10.1038/s41598-022-16885-x · Cited by 39
The Multi-Faceted Consequences of NRF2 Activation throughout Carcinogenesis
Occhiuto, C. J., Moerland, J. A., Leal, A. S., Gallo, K. A., & Liby, K. T. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.2191 · Cited by 43
Cancer cell plasticity, stem cell factors, and therapy resistance: how are they linked?
Fatma, H., & Siddique, H. R. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10144-9 · Cited by 40
CONIPHER: a computational framework for scalable phylogenetic reconstruction with error correction
Grigoriadis, K., Huebner, A., Bunkum, A., Colliver, E., Frankell, A. M., Hill, M. S., Thol, K., Birkbak, N. J., Swanton, C., Zaccaria, S., et al. (2023) · Nature Protocols · doi:10.1038/s41596-023-00913-9 · Cited by 42
Enriched variations in TEKT4 and breast cancer resistance to paclitaxel
Jiang, Y., Yu, K., Peng, W.-T., Di, G., Wu, J., Liu, G., & Shao, Z.-M. (2014) · Nature Communications · doi:10.1038/ncomms4802 · Cited by 40
Edge effects in game-theoretic dynamics of spatially structured tumours
Kaznatcheev, A., Scott, J. G., & Basanta, D. (2015) · Journal of The Royal Society Interface · doi:10.1098/rsif.2015.0154 · Cited by 41
Molecular evolution of colorectal cancer: from multistep carcinogenesis to the big bang
Amaro, A. A., Chiara, S., & Pfeffer, U. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9606-4 · Cited by 40
Plasticity of lung cancer stem-like cells is regulated by the transcription factor HOXA5 that is induced by oxidative stress
Saijo, H., Hirohashi, Y., Torigoe, T., Horibe, R., Takaya, A., Murai, A., Kubo, T., Kajiwara, T., Tanaka, T., Shionoya, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10571 · Cited by 40
High-grade serous ovarian cancer: the clone wars
Salomon‐Perzyński, A., Salomon-Perzyńska, M., Michalski, B., & Skrzypulec‐Plinta, V. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4292-1 · Cited by 43
CRISPR/Cas9 editing of the genome for cancer modeling
Guernet, A. A., & Grumolato, L. (2017) · Methods · doi:10.1016/j.ymeth.2017.03.007 · Cited by 44
Circulating Tumor DNA Analysis: Clinical Implications for Colorectal Cancer Patients. A Systematic Review
Bach, S., Sluiter, N. R., Beagan, J. J., Mekke, J. M., Ket, J. C. F., van Grieken, N. C. T., Steenbergen, R. D. M., Ylstra, B., Geert Kazemier, M., & Tuynman, J. B. (2019) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkz042 · Cited by 42
Stochasticity in the Genotype-Phenotype Map: Implications for the Robustness and Persistence of Bet-Hedging
Nichol, D., Robertson‐Tessi, M., Jeavons, P., & Anderson, A. R. A. (2016) · Genetics · doi:10.1534/genetics.116.193474 · Cited by 39
Combined aptamer and transcriptome sequencing of single cells
Delley, C. L., Liu, L., Sarhan, M. F., & Abate, A. R. (2018) · Scientific Reports · doi:10.1038/s41598-018-21153-y · Cited by 40
Minimal barriers to invasion during human colorectal tumor growth
Ryser, M. D., Mallo, D., Hall, A. H. S., Hardman, T., King, L. M., Tatishchev, S. F., Sorribes, I. C., Maley, C. C., Marks, J. R., Hwang, E. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14908-7 · Cited by 39
Self-citation
Single-cell RNA-seq reveals the immune escape and drug resistance mechanisms of mantle cell lymphoma
Wang, L., Mo, S., Li, X., He, Y., & Yang, H. J. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0073 · Cited by 42
MEDALT: single-cell copy number lineage tracing enabling gene discovery
Wang, F., Wang, Q., Mohanty, V., Liang, S., Dou, J., Han, J., Minussi, D. C., Gao, R., Ding, L., Navin, N. E., et al. (2021) · Genome biology · doi:10.1186/s13059-021-02291-5 · Cited by 39

Authors: Greaves, M., & Maley, C. C.
Affiliations: University of California, San Francisco (US)
ORCID: Maley, Carlo C.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2012-01
Volume: 481
Issue: 7381
Pages: 306-313
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature10762
PMC: PMC3367003
OpenAlex: W2023560061
Cited by: 3,162
References: 104
Citations by year: 2026: 180 · 2025: 160 · 2024: 181 · 2023: 225 · 2022: 204 · 2021: 253 · 2020: 229 · 2019: 211 · 2018: 247 · 2017: 296 · 2016: 247 · 2015: 238 · 2014: 221 · 2013: 164 · 2012: 101
FWCI: 17.27
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: National Cancer Institute (R01CA149566, P01CA091955, U54CA143803, P01CA91955, R01CA140657)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Keywords: clonal evolution, cancer, clonal expansion, genetic diversification, clonal selection, fitness landscape, tumor microenvironment, clonal architecture, drug resistance
MeSH terms: Animals, Clone Cells, Humans, Mutation, Neoplasms, Neoplastic Stem Cells, Genomics, Tumor Microenvironment, Clonal Evolution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clonal evolution in cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks